| SOXS 1.7999 0.55% | TPET 0.9723 131.50% | ONDS 10.9201 8.33% | STAK 0.6451 51.79% | NVDA 183.195 3.39% | TMDE 2.4421 164.81% | TURB 1.1 62.87% | EONR 0.4744 9.81% | XLE 56.535 1.10% | RYDE 0.3792 63.87% | NOK 8.18 5.96% | BHAT 0.0385 -22.22% | BITO 9.58 5.91% | USEG 1.1 2.80% | TQQQ 49.905 0.78% | IBIT 39.39 5.92% | TZA 6.125 -1.69% | PLUG 1.81 1.12% | NVD 7.01 -6.91% | MSTX 2.52 12.00% | TSLS 5.6299 -0.18% | AES 14.265 -17.45% | JDST 1.235 6.47% | BATL 9.41 70.47% | PLTR 146.31 6.65% | NFLX 96.895 0.68% | AAL 12.5999 -3.60% | TSLL 14.73 0.20% | SQQQ 70.298 -0.78% | QQQ 608.95 0.27% | HYG 80.24 -0.59% | ETHA 15.5687 7.22% | MARA 9.625 7.66% | XLF 51.345 -0.17% | SOFI 18.1699 2.31% | INTC 45.17 -0.96% | IWM 262.86 0.55% | CRCG 2.987 24.46% | BANL 0.6149 36.19% | NU 15.145 1.10% | TSLA 402.96 0.11% | TLT 89.385 -1.25% | BMNR 20.855 9.88% | BYND 0.8628 -8.76% | VG 11.235 15.94% | NIO 4.7 -3.49% | RCAT 13.62 16.91% | KOS 2.165 -7.08% | BKLN 20.215 0.02% | PBR 17.055 2.56%

Owens & Minor Sinks 34% After Q2 Miss And Segment Divestiture Plans

Owens & Minor (NYSE:OMI) shares tumbled 34% on Monday after posting second-quarter earnings below expectations and announcing plans to divest its Products & Healthcare Services segment.

Adjusted earnings from continuing operations were $0.26 per share, missing the $0.29 consensus. Revenue from continuing operations, mainly from the Patient Direct segment, rose 3.3% year-over-year to $681.9 million.

CEO Ed Pesicka said the company is in the final stages of selling the Products & Healthcare Services business and will operate as a focused Patient Direct company going forward.

Adjusted EBITDA from continuing operations increased to $96.6 million from $91.1 million a year earlier.

Published on: August 11, 2025